Last: | $2.39 |
---|---|
Change Percent: | 1.7% |
Open: | $2.37 |
Close: | $2.35 |
High: | $2.405 |
Low: | $2.3 |
Volume: | 165,837 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.39 | $2.37 | $2.35 | $2.405 | $2.3 | 165,837 | 07-22-2024 |
$2.35 | $2.29 | $2.35 | $2.39 | $2.29 | 108,007 | 07-19-2024 |
$2.33 | $2.39 | $2.33 | $2.46 | $2.26 | 174,155 | 07-18-2024 |
$2.42 | $2.37 | $2.42 | $2.45 | $2.35 | 237,734 | 07-17-2024 |
$2.42 | $2.38 | $2.42 | $2.5 | $2.32 | 571,757 | 07-16-2024 |
$2.32 | $2.47 | $2.32 | $2.49 | $2.28 | 748,442 | 07-15-2024 |
$2.48 | $2.47 | $2.48 | $2.57 | $2.45 | 231,680 | 07-12-2024 |
$2.5 | $2.15 | $2.5 | $2.51 | $2.11 | 1,016,417 | 07-11-2024 |
$2.11 | $2.12 | $2.11 | $2.1426 | $2.06 | 91,245 | 07-10-2024 |
$2.11 | $2.16 | $2.11 | $2.17 | $2.095 | 112,408 | 07-09-2024 |
$2.16 | $2.09 | $2.16 | $2.18 | $2.0845 | 156,174 | 07-08-2024 |
$2.09 | $2.06 | $2.09 | $2.13 | $2.03 | 251,573 | 07-05-2024 |
$2.08 | $2.06 | $2.08 | $2.09 | $2.05 | 69,905 | 07-04-2024 |
$2.08 | $2.06 | $2.08 | $2.09 | $2.05 | 69,905 | 07-03-2024 |
$2.06 | $2.08 | $2.06 | $2.1 | $2.04 | 106,191 | 07-02-2024 |
$2.12 | $2.28 | $2.12 | $2.28 | $2.05 | 497,106 | 07-01-2024 |
$2.28 | $2.17 | $2.28 | $2.3 | $2.1 | 934,088 | 06-28-2024 |
$2.2 | $2.21 | $2.2 | $2.23 | $2.12 | 165,481 | 06-27-2024 |
$2.21 | $2.11 | $2.21 | $2.25 | $2.1001 | 216,929 | 06-26-2024 |
$2.13 | $2.23 | $2.13 | $2.23 | $2.13 | 162,391 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Solo Brands Inc. Class A Company Name:
DTC Stock Symbol:
NYSE Market:
Solo Brands Inc. Class A Website:
CHUBBIES UNVEILS TEAM USA CAPSULE SERIES: A MULTI-YEAR CELEBRATION OF AMERICA'S OLYMPIC LEGACY PR Newswire The 2024 Three-Part Series Honors Past, Present, and Future Champions AUSTIN, Texas , July 12, 2024 /PRNewswire/ -- Chubbies , the weekend-c...
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that it...
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that De...